Data Mining in Pharmacovigilance Manfred HaubenVaishali PatadiaLester Reich Current Opinion 20 November 2012 Pages: 835 - 842
Impact Analysis of Signals Detected from Spontaneous Adverse Drug Reaction Reporting Data Patrick WallerEmma HeeleyJane Moseley Leading Article 20 November 2012 Pages: 843 - 850
Clarification of Terminology in Drug Safety Jeffrey K. AronsonRobin E. Ferner Leading Article 20 November 2012 Pages: 851 - 870
Benefit-Risk Assessment of Levetiracetam in the Treatment of Partial Seizures Bassel Abou-Khalil Review Article 20 November 2012 Pages: 871 - 890
The Incidence of Prescribing Errors in Hospital Inpatients Bryony Dean FranklinCharles VincentNick Barber Review Article 20 November 2012 Pages: 891 - 900
Testing and Implementing Signal Impact Analysis in a Regulatory Setting Emma HeeleyPatrick WallerJane Moseley Original Research Article 20 November 2012 Pages: 901 - 906
Fatal Venous Thromboembolism Associated with Different Combined Oral Contraceptives Karin HedenmalmEva Samuelsson Original Research Article 20 November 2012 Pages: 907 - 916
Comparison of Reporting of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Selective COX-2 Inhibitors Lois La GrenadeLauren LeeAllen Brinker Original Research Article 20 November 2012 Pages: 917 - 924
5th ISoP Annual Meeting ‘Pharmacovigilance — A Global Concern: East Meets West’ Abstracts 20 November 2012 Pages: 925 - 969